Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Evodental

Explore full profile

Full-jaw dental implants using advanced digital technology

London, United KingdomFounded 2007Biotech & Life Sciences
Valuation $25–50M Last recorded · 2018
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Total funding $0–10M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Evodental and the history behind them.

About Evodental

Evodental operates a network of dental clinics across the United Kingdom specializing exclusively in full-mouth dental implant solutions. The company was founded in 2007 by Dr. Rajesh Vijay (also cited as Dr. R.P. Vijayanarayanan), who was motivated to find a better solution for his wife's long-term oral health issues. Co-founded by Manoj Vijayanarayanan, who serves as Operations Director, the company has grown to a team of over 100 professionals.

The business model centers on providing comprehensive, technologically advanced full-jaw reconstruction, often in a single day, a procedure it brands as the "EvoSolution™". This is positioned as an alternative to traditional dentures or failing teeth for patients with issues like advanced gum disease or bone loss. The company integrates digital workflows, including 3D scanning and the in-house additive manufacturing of prosthetics, which allows for precision-engineered, bespoke solutions. This vertical integration, with on-site labs at each clinic, enables quality control and the ability to perform complex procedures efficiently.

Evodental's target market consists of individuals seeking permanent solutions for severe dental problems. The company makes money by providing these specialized, high-value dental procedures. It offers several tiered treatment packages, such as EvoEssential, EvoAdvanced, and EvoUltimate, with transparent pricing and financing options available. The company has secured significant investment to fuel its expansion, including a £4 million Series A round in 2018 from the British Growth Fund (BGF) to advance its 3D printing capabilities and open new clinics across the UK.

Source: Dealroom company data

At a glance

Founded
2007
Headquarters
London, United Kingdom
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • YFM Equity Partners

Series B and later1 investor entered at this stage

  • Business Growth Fund
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇬🇧 United Kingdom100%
1 country shown
Web traffic by country
47K monthly visits
across markets
🇬🇧 United Kingdom93.6%
🇺🇸 United States3%
🇮🇳 India1.5%
🇵🇰 Pakistan0.9%
🇧🇬 Bulgaria0.2%
Top 5 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Evodental on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Evodental on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.